Mutagenesis of the human IgA1 heavy chain tailpiece that prevents dimer assembly.

Mutagenesis of the human IgA1 heavy chain tailpiece that prevents dimer assembly.

The structural features of the human IgA1 tailpiece required for interaction with J chain in IgA dimer assembly were investigated using a protein engineering approach. Wild-type and mutant forms of IgA1 were expressed in the mouse myeloma cell line, J558L, which endogenously expresses J chain. Wild-...

Bibliografski detalji
Glavni autori:	Atkin, J, Pleass, R, Owens, R, Woof, J
Format:	Journal article
Jezik:	English
Izdano:	1996

Slični predmeti

Efficient N-Glycosylation of the Heavy Chain Tailpiece Promotes the Formation of Plant-Produced Dimeric IgA
od: Kathrin Göritzer, i dr.
Izdano: (2020-04-01)

Propensity of IgA to self-aggregate via tailpiece cysteine-471 and treatment of IgA nephropathy using cysteamine
od: Xinfang Xie, i dr.
Izdano: (2021-10-01)

Purification and characterization of chimeric human IgA1 and IgA2 expressed in COS and Chinese hamster ovary cells.
od: Morton, H, i dr.
Izdano: (1993)

Development of a human IgA antibody specific for the tumor antigen TAG-72
od: Ingram, P, i dr.
Izdano: (1996)

Development of a human IgA antibody specific for the tumour antigen TAG-72.
od: Ingram, P, i dr.
Izdano: (1997)

Dimeric and polymeric IgA, but not monomeric IgA, enhance the production of IL-6 by human renal mesangial cells
od: T. J. F. Reterink, i dr.
Izdano: (1996-01-01)

Rabbit IgA Hinges That Resist IgA1 Protease Action Provide Options for Improved IgA-Based Therapeutic Agents
od: Patrícia de Sousa-Pereira, i dr.
Izdano: (2022-06-01)

The generation and evaluation of recombinant human IgA specific for Plasmodium falciparum merozoite surface protein 1-19 (PfMSP1₁₉)
od: Shi, J, i dr.
Izdano: (2011)

Neuraminidase treatment abrogates the binding abnormality of IgA1 from IgA nephropathy patients and the differential charge distribution of its alpha-heavy chains
od: Hashim, Onn Haji, i dr.
Izdano: (2001)

Some like it hot: Variable impact of a tailpiece heating device on different gram-negative bacteria
od: Stacy Park, i dr.
Izdano: (2023-06-01)

Abnormal Aspects of IgA in IgA Nephropathy
od: Akash Nabil, i dr.
Izdano: (2000-01-01)

Heavy chain dimers stabilized by disulfide bonds are required to promote in vitro assembly of trastuzumab
od: Mercè Farràs, i dr.
Izdano: (2020-01-01)

Comparison of IgA Endomysium Antibody and IgA Tissue Transglutaminase Antibody in Celiac Disease
od: Helen R Gillett, i dr.
Izdano: (2000-01-01)

Serological Measurement of Poly-IgA Immune Complex Levels in IgA Nephropathy and IgA Vasculitis
od: Xue Zhang, i dr.
Izdano: (2022-07-01)

Sera of IgA nephropathy patients contain a heterogeneous population of relatively cationic alpha-heavy chains
od: Shuib, A.S., i dr.
Izdano: (1998)

IgA antibodies to laminin 5 are not present in linear IgA disease
od: Ali, I, i dr.
Izdano: (2003)

SARS-CoV-2 Accessory Protein ORF8 Targets the Dimeric IgA Receptor pIgR
od: Frederique Laprise, i dr.
Izdano: (2024-06-01)

A comparison of IgA positive and IgA negative dapsone responsive dermatoses.
od: Fry, L, i dr.
Izdano: (1980)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
od: Yoshihito Nihei, i dr.
Izdano: (2023-04-01)

Plasma D-dimer as a potential predictor of progression in IgA nephropathy: a cohort study
od: Guizhen Yu, i dr.
Izdano: (2023-12-01)

Identification of a new European rabbit IgA with a serine-rich hinge region.
od: Ana Pinheiro, i dr.
Izdano: (2018-01-01)

Autoantibodies Specific for Galactose-Deficient IgA1 in IgA Vasculitis With Nephritis
od: Hitoshi Suzuki, i dr.
Izdano: (2019-12-01)

The Functional Role of IgA in the IgM/IgA-Enriched Immunoglobulin Preparation Trimodulin
od: Fabian Bohländer, i dr.
Izdano: (2021-12-01)

Linear IgA disease: the IgA and IgG response to the epidermal antigens demonstrates that intermolecular epitope spreading is associated with IgA rather than IgG antibodies, and is more common in adults.
od: Allen, J, i dr.
Izdano: (2003)

Dermal binding linear IgA disease: is this the IgA equivalent of epidermolysis bullosa acquisita?
od: Lally, A, i dr.
Izdano: (2005)

IgA and IgG hypogammaglobulinemia in Waldenström’s macroglobulinemia
od: Zachary R. Hunter, i dr.
Izdano: (2010-03-01)

Cutaneous IgA subclasses in dermatitis herpetiformis and linear IgA disease.
od: Wojnarowska, F, i dr.
Izdano: (1988)

Nefropatia por IgA nas espondiloartrites IgA nephropathy in spondyloarthritis
od: Daniela Castelo Azevedo, i dr.
Izdano: (2011-02-01)

IgA pemphigus showing IgA antibodies to desmoglein 1 and 3
od: Salama Hegazy, i dr.
Izdano: (2016-10-01)

Harnessing Nasal Immunity with IgA to Prevent Respiratory Infections
od: John Joseph
Izdano: (2022-10-01)

Linear IgA disease: the IgA and IgG response to dermal antigens demonstrates a chiefly IgA response to LAD285 and a dermal 180-kDa protein.
od: Allen, J, i dr.
Izdano: (2003)

The generation and evaluation of recombinant human IgA specific for <it>Plasmodium falciparum </it>merozoite surface protein 1-19 (<it>Pf</it>MSP1<sub>19</sub>)
od: Corran Patrick H, i dr.
Izdano: (2011-07-01)

Relationship between Gd-IgA1 and TNFR1 in IgA nephropathy and IgA vasculitis nephritis in children – multicenter study
od: Małgorzata Mizerska-Wasiak, i dr.
Izdano: (2021-08-01)

HLA-B27 HEAVY CHAIN DIMER EXPRESSION IN SPONDYLOARTHRITIS
od: Rysnik, O, i dr.
Izdano: (2012)

Aberrantly Glycosylated IgA1 as a Factor in the Pathogenesis of IgA Nephropathy
od: Mototsugu Tanaka, i dr.
Izdano: (2011-01-01)

The origin and activities of IgA1-containing immune complexes in IgA nephropathy
od: Barbora eKnoppova, i dr.
Izdano: (2016-04-01)

Aberrant IgA1 Glycosylation in IgA Nephropathy: A Systematic Review.
od: Qiang Sun, i dr.
Izdano: (2016-01-01)

IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection
od: Isabella Quinti, i dr.
Izdano: (2021-04-01)

Transient IgA, steady IgG?
od: Berthold, DL, i dr.
Izdano: (2020)

Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression.
od: Dita Maixnerova, i dr.
Izdano: (2019-01-01)